BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 18486822)

  • 1. Lesions of the corpus callosum in children with neurofibromatosis 1.
    Mimouni-Bloch A; Kornreich L; Kaadan W; Steinberg T; Shuper A
    Pediatr Neurol; 2008 Jun; 38(6):406-10. PubMed ID: 18486822
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Corpus callosum morphology and its relationship to cognitive function in neurofibromatosis type 1.
    Pride N; Payne JM; Webster R; Shores EA; Rae C; North KN
    J Child Neurol; 2010 Jul; 25(7):834-41. PubMed ID: 20142468
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Corpus callosum tumor as the presenting symptom of neurofibromatosis type 1 in a patient and literature review].
    Pascual-Castroviejo I; Pascual-Pascual SI; Velazquez-Fragua R; Viaño J
    Rev Neurol; 2012 Nov; 55(9):528-32. PubMed ID: 23111991
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Associated brain anomalies and clinical findings in corpus callosum dysgenesis].
    Alkan A; Kutlu R; Baysal T; Siğirci A; Altinok T; Orkan I; Hallaç T; Saraç K
    Tani Girisim Radyol; 2003 Dec; 9(4):411-7. PubMed ID: 14730948
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neurofibromatosis type 1 and optic pathway gliomas: follow-up of 54 patients.
    Thiagalingam S; Flaherty M; Billson F; North K
    Ophthalmology; 2004 Mar; 111(3):568-77. PubMed ID: 15019338
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identifying Lesions of the Corpus Callosum in Patients With Neurofibromatosis Type 1.
    Jandhyala NR; Garcia MR; Kim M; Yohay K; Segal D
    Pediatr Neurol; 2024 Jul; 156():66-71. PubMed ID: 38733856
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Focal lesion in the splenium of the corpus callosum in epileptic patients: antiepileptic drug toxicity?
    Kim SS; Chang KH; Kim ST; Suh DC; Cheon JE; Jeong SW; Han MH; Lee SK
    AJNR Am J Neuroradiol; 1999 Jan; 20(1):125-9. PubMed ID: 9974067
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neurological complications involving the central nervous system in neurofibromatosis type 1.
    Hsieh HY; Wu T; Wang CJ; Chin SC; Chen YR
    Acta Neurol Taiwan; 2007 Jun; 16(2):68-73. PubMed ID: 17685129
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of possible prognostic factors of fulminant acute disseminated encephalomyelitis (ADEM) on magnetic resonance imaging with fluid-attenuated inversion recovery (FLAIR) and diffusion-weighted imaging.
    Donmez FY; Aslan H; Coskun M
    Acta Radiol; 2009 Apr; 50(3):334-9. PubMed ID: 19235577
    [TBL] [Abstract][Full Text] [Related]  

  • 10. When does human brain development end? Evidence of corpus callosum growth up to adulthood.
    Pujol J; Vendrell P; Junqué C; Martí-Vilalta JL; Capdevila A
    Ann Neurol; 1993 Jul; 34(1):71-5. PubMed ID: 8517683
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prospective neuroimaging study in hereditary spastic paraplegia with thin corpus callosum.
    França MC; D'Abreu A; Maurer-Morelli CV; Seccolin R; Appenzeller S; Alessio A; Damasceno BP; Nucci A; Cendes F; Lopes-Cendes I
    Mov Disord; 2007 Aug; 22(11):1556-62. PubMed ID: 17516453
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [A combination of generalized neurofibromatosis (Recklinghausen disease) and agenesis of the corpus callosum].
    Toedt C; Hötzinger H; Salbeck R; Beyer HK
    Digitale Bilddiagn; 1989 Sep; 9(3):105-6. PubMed ID: 2512044
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Spectrum of corpus callosum agenesis.
    Sztriha L
    Pediatr Neurol; 2005 Feb; 32(2):94-101. PubMed ID: 15664768
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neurofibromatosis type 1 and optic pathway glioma. A long-term follow-up.
    Lama G; Esposito Salsano M; Grassia C; Calabrese E; Grassia MG; Bismuto R; Melone MA; Russo S; Scuotto A
    Minerva Pediatr; 2007 Feb; 59(1):13-21. PubMed ID: 17301720
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Marchiafava-Bignami disease: magnetic resonance imaging findings in corpus callosum and subcortical white matter.
    Kawarabuki K; Sakakibara T; Hirai M; Yoshioka Y; Yamamoto Y; Yamaki T
    Eur J Radiol; 2003 Nov; 48(2):175-7. PubMed ID: 14680909
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Hemorrhagic lesion of the corpus callosum in influenza-associated encephalitis].
    Burillon M; Cheuret E; Chaix Y
    Arch Pediatr; 2010 May; 17(5):491-4. PubMed ID: 20338734
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Corpus callosum agenesis].
    Gonçalves-Ferreira T; Sousa-Guarda C; Oliveira-Monteiro JP; Carmo-Fonseca MJ; Filipe-Saraiva P; Goulão-Constâncio A
    Rev Neurol; 2003 Apr 16-30; 36(8):701-6. PubMed ID: 12717644
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Corpus callosum size in children with spastic cerebral palsy: relationship to clinical outcome.
    Kułak W; Sobaniec W; Kubas B; Walecki J
    J Child Neurol; 2007 Apr; 22(4):371-4. PubMed ID: 17621513
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An unusual case of hearing loss and cerebellar pathology.
    Joossens K; Demaerel P; Legius B
    JBR-BTR; 2002; 85(5):252-3. PubMed ID: 12463501
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cerebrovascular abnormalities in a population of children with neurofibromatosis type 1.
    Rosser TL; Vezina G; Packer RJ
    Neurology; 2005 Feb; 64(3):553-5. PubMed ID: 15699396
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.